FDA Approved: VALRUBICIN INTRAVESICAL SOLUTION — Original Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved Hikma's generic valrubicin intravesical solution (ANDA 206430) for carcinoma in situ of the bladder in patients who have failed prior therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carcinoma in Situ of the Bladder

Drugs mentioned

• VALRUBICIN INTRAVESICAL SOLUTION (valrubicin intravesical solution)

Snippet

ORIG AP for VALRUBICIN INTRAVESICAL SOLUTION (VALRUBICIN INTRAVESICAL SOLUTION)